Trial
NCT01894594
Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Hospitals Cleveland Medical Center
Collaborators
—
Condition
Sickle Cell Anemia
Intervention
Sodium Bicarbonate
Why stopped
Poor recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-20